Ruitai Biotechnology

company

About

Ruitai is a developer for ophthalmic regenerative medicine, specialising in the R&D and sale of repair materials and medical device products

  • 51 - 100

Details

Last Funding Type
Series A
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Ruitai Biotechnology has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 26, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 26, 2022 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ruitai Biotechnology is funded by 1 investors. Nanjing Enran Ruiguang Health Industry Investment Partnership are the most recent investors.
Investor Name Lead Investor Funding Round
Nanjing Enran Ruiguang Health Industry Investment Partnership Series A